Skip to content
AdAdvertisement
Value Science Weekly — health economics and market access, in your inbox

Latest News — Page 73

Paediatric Biobanks

Clinical Guidelines And Protocols

The Power of Paediatric Biobanks: Advancing Child Health Research

🚀 The CHOP Biobank is transforming paediatric healthcare by collecting and analysing biospecimens and health data. Learn how this initiative is advancing child health research and improving outcomes.

#SyenzaNews #PaediatricHealthcare #Biobanking #ChildHealth #ResearchInnovation

Want to learn more? Follow the link for our latest update.

Syenza TeamRead ›
Cost-effectiveness of immune checkpoint inhibitors

Comparative Effectiveness Research

Cost-Effectiveness of Immune Checkpoint Inhibitors in Advanced Endometrial Cancer

⭐ Cost-Effectiveness of Immune Checkpoint Inhibitors in Advanced Endometrial Cancer 💰

🔬 Exploring the financial impact of immune checkpoint inhibitors in advanced endometrial cancer! Discover how innovative treatments are reshaping patient care and healthcare policies. 📊

#SyenzaNews #EndometrialCancer #Immunotherapy #CostEffectiveness #MedicalResearch

Call to Action: Stay informed on the latest advancements in endometrial cancer care! Read the full article for valuable insights. 💡

Syenza TeamRead ›
Revealing the Hidden Impact: Family Spillover Effects

Cost Utility Analysis

Revealing the Hidden Impact: Family Spillover Effects

In every patient’s journey, their loved ones play a crucial role in providing support and care 🤗 Understanding the profound impact of caring for an unwell family member is becoming increasingly important. In this article, we share some insight into the challenges of accounting for the mental health and financial effects on family members when conducting economic evaluations for paediatric health interventions 🧸

#SyenzaNews #Healthcare #PaediatricHealth #EconomicEvaluations #HTA

Syenza TeamRead ›
Digital interventions

Comparative Effectiveness Research

From Skepticism to Support: Healthcare Providers’ Acceptance of Digital Interventions in Substance Used Disorders Treatment in Kenya

From Skepticism to Support: Healthcare Providers’ Acceptance of Digital Interventions in SUD Treatment in Kenya💡

Healthcare providers in Kenya show high acceptance of digital interventions for substance use disorder treatment. Learn more about how technology is shaping healthcare delivery.
#SyenzaNews #HealthcareInnovation #DigitalInterventions #SubstanceUseDisorder #KenyaHealthcare 🏥💻

Syenza TeamRead ›
AI medical devices regulation

Artificial Intelligence And Machine Learning

Modernising AI Medical Devices Regulation: FDA’s Firm-Based Approach

📢 #SyenzaNews: The FDA is modernising regulations for AI medical devices with a firm-based approach. This shift focuses on the quality systems of manufacturing firms rather than individual product mechanics.
Discover how this new method can enhance safety and foster innovation in healthcare.

Read more here.

#LifeSciences #HealthcareInnovation #AIMedicalDevices #FDARegulations #HealthTech

Syenza TeamRead ›
Abu Dhabi healthcare partnerships

Alzheimer's Disease

Abu Dhabi Strategic Healthcare Partnerships: Global Collaborations

Abu Dhabi is making remarkable progress in healthcare through strategic partnerships with leading institutions like CHOP and Penn Medicine. These collaborations aim to advance paediatric oncology, gene therapy, and translational research. 🌍💉

#SyenzaNews #HealthcareInnovation #PaediatricOncology #GeneTherapy #TranslationalResearch #AbuDhabiHealthcare

Read more about how these partnerships are set to transform healthcare in Abu Dhabi and beyond.

Syenza TeamRead ›
Genome-wide sequencing in rare diseases

Clinical Guidelines And Protocols

Genome-Wide Sequencing in Diagnosing Rare Diseases: Clinical and Economic Implications

🌟 Discover the economic impact of genome-wide sequencing on healthcare costs for rare diseases. Our latest study reveals intriguing findings from England and Canada. Explore how GWS is reshaping healthcare dynamics. #SyenzaNews #HealthcareInnovation #GenomeSequencing #RareDiseases #HealthcareCosts

Syenza TeamRead ›
Antenatal HCV Screening in Egypt: Paving the Path to Elimination

Cost Effectiveness Analysis

Antenatal HCV Screening in Egypt: Paving the Path to Elimination

Egypt has made amazing strides in eliminating Hepatitis C. In less than 10 years, Egypt has transitioned from having the highest rate of HCV to one of the lowest rates globally, becoming the first country in the world to reach WHO gold-tier status on the path to eliminating HCV 🥇

Sadly, pregnant women and children are currently not included in the Egyptian national treatment strategy. This article highlights the importance of including these populations and explores cost-effective screening and testing strategies to truly eliminate HCV in Egypt 🌍

#SyenzaNews #PublicHealth #Healthcare #Hepatitis

Syenza TeamRead ›
Health Economic Assessment of Nirsevimab for Respiratory Syncytial Virus in High-Risk Infants

Clinical Trials

Health Economic Assessment of Nirsevimab for Respiratory Syncytial Virus in High-Risk Infants

🌟 The Study Highlights Cost-Effectiveness of Nirsevimab for RSV in Infants!🌟

A recent analysis shows that nirsevimab can significantly reduce RSV-related hospitalisations and ER visits, saving SAR 274–343 million in healthcare costs in Saudi Arabia. This breakthrough offers a promising strategy to improve infant health outcomes.

#SyenzaNews #RSV #Nirsevimab #CostEffectiveness #SaudiArabia

Syenza TeamRead ›
burden of liver transplantation for Hepatitis B

Europe

The Economic Burden of Liver Transplantation for Hepatitis B in Italy

🌟 The Economic Burden of Liver Transplantation for Hepatitis B in Italy 🌟

🏥 🩺 Liver transplantation is a critical treatment for end-stage liver disease caused by Hepatitis B. Our latest insight article explores the economic impact and patient management strategies in Italy. Discover how tailored HBV prophylaxis and effective healthcare strategies can improve patient outcomes and reduce costs. 💊 💰

📊 Key findings include:

• Average lifetime direct healthcare cost per HBV patient: €395,986.
• Discounted lifetime financial impact on the Italian National Health System: €92.3 million.

#SyenzaNews #HepatitisB #LiverTransplantation #EconomicBurden #PatientCare

Syenza TeamRead ›
brain cancer care coordinators

Clinical Guidelines And Protocols

Impact of Brain Cancer Care Coordinators on Healthcare Utilisation

🏥✨Discover how brain cancer care coordinators are enhancing patient care and reducing healthcare costs. Learn about their impact on emergency department visits and hospital admissions. 🧠💪

#SyenzaNews #GBM #BrainCancer #PatientCareImprovement #HealthcareCoordination

👉 Call to Action: Learn more about the impact of coordinated care in glioblastoma management!

Syenza TeamRead ›
Rare Diseases: Modern Strategies for Enhanced Primary Care

Artificial Intelligence And Machine Learning

Rare Diseases: Modern Strategies for Enhanced Primary Care

This paper underscores the critical role of primary care in addressing the unmet needs of patients with rare diseases, highlighting the necessity for a multifaceted approach. Improving accessibility, early diagnosis, professional training, and digital health innovations can enhance treatment and overall care 🧑🏽‍⚕️ Strengthening primary care systems can improve health outcomes and quality of life for the approximately 300 million people and their families affected by rare diseases globally 🌍 #SyenzaNews #RareDiseases #HealthcareInnovation #HealthTech

Syenza TeamRead ›
Challenges and Opportunities in Educating the Public About Childhood Arthritis in the UK

Europe

Challenges and Opportunities in Educating the Public About Childhood Arthritis in the UK

🌟 Raising Awareness for Childhood Arthritis in the UK 🌟

The article highlights a critical issue: low awareness of childhood arthritis in the UK. Let’s change that narrative together!

Join us in advocating for improved education and support for children with arthritis. Together, we can make a difference! 💪💙
#SyenzaNews #ChildhoodArthritisAwareness #HealthEquity #CommunitySupport

Syenza TeamRead ›
Access to Essential Medicines for Rheumatic Diseases in Children

Axial Spondyloarthritis

Access to Essential Medicines for Rheumatic Diseases in Children

🌍 Did you know that only four African countries have updated their National Essential Medicines Lists since 2021 to include modern treatments for rheumatic diseases in children? This gap highlights the urgent need for policy development and innovative financing strategies. Let’s work together to ensure every child has access to the medicines they need.

#SyenzaNews #Healthcare #RheumaticDiseases #EssentialMedicines #UniversalHealthCoverage

📢 Learn more about how we can improve access to essential medicines for children with rheumatic diseases in Africa. Read our latest article!

Syenza TeamRead ›
Paediatric Rheumatology in Africa

Axial Spondyloarthritis

Paediatric Rheumatology Care in Africa: Hope and Resilience

🌟 #SyenzaNews 🌟 Discover how PAFLAR is advancing paediatric rheumatology care in Africa! From empowering Therapeutic Patient Education workshops to inspiring stories of dedicated professionals, learn about the strides being made to improve the lives of children with rheumatic diseases. 🌍👩‍⚕️👨‍⚕️

#PaediatricRheumatology #HealthcareInnovation #PatientEducation #MedicalAdvocacy #GlobalHealth #JIA

🩺 Together, we can make a difference!

Syenza TeamRead ›
Economic burden of Juvenile Idiopathic Arthritis

Biologics And Biosimilars

Economic Burden of Juvenile Idiopathic Arthritis in Spain

🔍 Understanding the Economic Burden of Juvenile Idiopathic Arthritis (JIA) in Spain 🇪🇸

👨‍👩‍👧‍👦 JIA affects many children, leading to significant direct and indirect costs. Discover how biologic therapies, medical visits, and family impacts contribute to the overall burden. 🏥

👉 For more insights into the economic impact of chronic diseases and innovative healthcare solutions, follow our page and stay updated with the latest research.

#SyenzaNews #JuvenileArthritis #ChronicDisease #EconomicBurden #PatientOutcomes #HealthEconomics 📊

Syenza TeamRead ›